MSD Gulf Commited to bringing out the best in medicine
Contact UsMerck Worldwide
   
Healthcare Professionals MSD Gulf About Us Products Contact us
Email Updates
Request More Information


SINGULAIR for Asthma

TARGET DUAL PATHWAYS OF INFLAMMATION1,2

EFFECTIVE CONTROL OF INFLAMMATION3–6
 Blocks the important leukotriene pathway7–9
 Steroids do not block the formation of leukotrienes in the airways of asthmatics9–12

EFFECTIVELY REDUCES SYMPTOMS
An effective alternative
 To increasing the dose of steroids8,13
To adding a long-acting beta-agonist4

IS EASY TO MANAGE
 
Once-daily tablet, no complicated devices
 Excellent tolerability




Prescribed for over 33 million patients worldwide14*

*Since 1997. Data as of June 2004.
View referencesView References PrintPrint

Before prescribing, please consult the full product circular.
† Trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA

Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA) Disclaimer